CLOs on the Move

Doc Magi Productions

www.docmagi.com

 
Doc Magi Productions is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.docmagi.com
  • 25721 Leticia Dr
    Valencia, CA USA 91355
  • Phone: 661.286.2179

Executives

Name Title Contact Details

Similar Companies

Lush Fresh Handmade Cosmetics

We believe in making effective products from fresh, organic fruit and vegetables, the finest essential oils and safe synthetics. We invent our own products and fragrances. We make them fresh by hand using little or no preservative or packaging, using only vegetarian ingredients, and tell you when they were made. We believe in buying ingredients only from companies that do not commission tests on animals and in testing our products on humans. We believe in happy people making happy soap, putting our faces on our products and making our mums proud. We believe in long candlelit baths, sharing showers, massage, filling the world with perfume and in the right to make mistakes, lose everything and start again. We believe our products are good value, that we should make a profit and that the customer is always right.

Greenwood Nursing and Rehabilitation Center

Greenwood Nursing and Rehabilitation Center is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allergy Control Products

Allergy Control Products is a Danbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bronner Brothers Cosmetics

Bronner Brothers Cosmetics is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Cipla

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla`s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla`s research and development focuses on developing innovative products and drug delivery systems.